BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11054426)

  • 1. Circular minichromosomes become highly recombinogenic in topoisomerase-deficient yeast cells.
    Trigueros S; Roca J
    J Biol Chem; 2001 Jan; 276(3):2243-8. PubMed ID: 11054426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to relax negative supercoiling of DNA is a primary cause of mitotic hyper-recombination in topoisomerase-deficient yeast cells.
    Trigueros S; Roca J
    J Biol Chem; 2002 Oct; 277(40):37207-11. PubMed ID: 12151411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings.
    Kim RA; Wang JC
    Cell; 1989 Jun; 57(6):975-85. PubMed ID: 2544296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II.
    Goto T; Wang JC
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7178-82. PubMed ID: 2997777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II.
    Christman MF; Dietrich FS; Fink GR
    Cell; 1988 Nov; 55(3):413-25. PubMed ID: 2902925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.
    Wasserman RA; Wang JC
    Cancer Res; 1994 Apr; 54(7):1795-800. PubMed ID: 8137294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerases Modulate the Timing of Meiotic DNA Breakage and Chromosome Morphogenesis in
    Heldrich J; Sun X; Vale-Silva LA; Markowitz TE; Hochwagen A
    Genetics; 2020 May; 215(1):59-73. PubMed ID: 32152049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global transcription regulation by DNA topoisomerase I in exponentially growing Saccharomyces cerevisiae cells: activation of telomere-proximal genes by TOP1 deletion.
    Lotito L; Russo A; Chillemi G; Bueno S; Cavalieri D; Capranico G
    J Mol Biol; 2008 Mar; 377(2):311-22. PubMed ID: 18272174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the yeast TOP3 gene product as a single strand-specific DNA topoisomerase.
    Kim RA; Wang JC
    J Biol Chem; 1992 Aug; 267(24):17178-85. PubMed ID: 1324925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutants.
    Brill SJ; Sternglanz R
    Cell; 1988 Jul; 54(3):403-11. PubMed ID: 2840207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topoisomerase I controls the kinetics of promoter activation and DNA topology in Saccharomyces cerevisiae.
    Di Mauro E; Camilloni G; Verdone L; Caserta M
    Mol Cell Biol; 1993 Nov; 13(11):6702-10. PubMed ID: 8413266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase function during replication-independent chromatin assembly in yeast.
    Garinther WI; Schultz MC
    Mol Cell Biol; 1997 Jul; 17(7):3520-6. PubMed ID: 9199287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and genetic mapping of the DNA topoisomerase II gene of Saccharomyces cerevisiae.
    Voelkel-Meiman K; DiNardo S; Sternglanz R
    Gene; 1986; 42(2):193-9. PubMed ID: 3015732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and expression of the Candida albicans TOP2 gene allows study of fungal DNA topoisomerase II inhibitors in yeast.
    Keller BA; Patel S; Fisher LM
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):329-39. PubMed ID: 9164874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of mutants of Saccharomyces cerevisiae requiring DNA topoisomerase I.
    Sadoff BU; Heath-Pagliuso S; Castaño IB; Zhu Y; Kieff FS; Christman MF
    Genetics; 1995 Oct; 141(2):465-79. PubMed ID: 8647385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.
    Salceda J; Fernández X; Roca J
    EMBO J; 2006 Jun; 25(11):2575-83. PubMed ID: 16710299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxorubicin: implications for the mechanisms of doxorubicin action and cytotoxicity.
    Patel S; Sprung AU; Keller BA; Heaton VJ; Fisher LM
    Mol Pharmacol; 1997 Oct; 52(4):658-66. PubMed ID: 9380029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large circular minichromosome of Schizosaccharomyces pombe requires a high dose of type II DNA topoisomerase for its stabilization.
    Murakami S; Yanagida M; Niwa O
    Mol Gen Genet; 1995 Mar; 246(6):671-9. PubMed ID: 7898434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between Top1 and Mms21/Nse2 mediated sumoylation in stable maintenance of long chromosomes.
    Mahendrawada L; Rai R; Kothiwal D; Laloraya S
    Curr Genet; 2017 Aug; 63(4):627-645. PubMed ID: 27872982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human DNA topoisomerases II alpha and II beta can functionally substitute for yeast TOP2 in chromosome segregation and recombination.
    Jensen S; Redwood CS; Jenkins JR; Andersen AH; Hickson ID
    Mol Gen Genet; 1996 Aug; 252(1-2):79-86. PubMed ID: 8804406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.